To further elucidate the mechanism underlying the effect of Tofo on HFD‐induced renal injury in the medaka model of NASH, we assessed the expression levels of 8‐OHdG and GPX1 in the renal tissues using immunohistochemical analyses (Fig. 2). Here, GPX1 is linked to metabolic dysfunction-associated steatohepatitis.